Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP)

CUSIP: 45339J105

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
113,265,306
Total 13F shares
602,239
Share change
+31,710
Total reported value
$1,058,915
Price per share
$1.76
Number of holders
18
Value change
+$56,020
Number of buys
8
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 45339J105?
CUSIP 45339J105 identifies INDP - Indaptus Therapeutics Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP) as of Q4 2023

As of 31 Dec 2023, Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 602,239 shares. The largest 10 holders included VANGUARD GROUP INC, INVESTMENT HOUSE LLC, GEODE CAPITAL MANAGEMENT, LLC, STRATEGY ASSET MANAGERS LLC, Pine Valley Investments Ltd Liability Co, RENAISSANCE TECHNOLOGIES LLC, Vivaldi Capital Management LP, STATE STREET CORP, CITADEL ADVISORS LLC, and Tower Research Capital LLC (TRC). This page lists 18 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.